Europe 'panicking' over India's pharmaceutical export curbs: industry group
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Monday
January 30, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
MONDAY, JANUARY 30, 2023
Europe 'panicking' over India's pharmaceutical export curbs: industry group

Coronavirus chronicle

Reuters
04 March, 2020, 05:40 pm
Last modified: 04 March, 2020, 05:53 pm

Related News

  • If Turkey blocks Sweden and Finland, will NATO boot Turkey?
  • Europeans dial down the heating, heed calls to save energy
  • EU plans changes to pharmaceuticals law to avoid medicine shortages
  • Davos 2023: EU to counter US climate game changer with own green deal
  • EU should put Twitter under direct supervision after missteps: German official

Europe 'panicking' over India's pharmaceutical export curbs: industry group

Indian drug makers rely on China, the source of the virus outbreak, for almost 70 percent of the APIs for their medicines

Reuters
04 March, 2020, 05:40 pm
Last modified: 04 March, 2020, 05:53 pm
FILE PHOTO: Employees inspect tablets as they move along the production line at a pharmaceutical plant of Lupin, India's No. 2 drugmaker, in Verna, in the western state of Goa, India, June 9, 2017. REUTERS/Danish Siddiqui
FILE PHOTO: Employees inspect tablets as they move along the production line at a pharmaceutical plant of Lupin, India's No. 2 drugmaker, in Verna, in the western state of Goa, India, June 9, 2017. REUTERS/Danish Siddiqui

India's top pharmaceuticals export group said the government's curbs on some drug exports amid the spreading coronavirus outbreak has caused panic in Europe and will severely impact businesses in the sector.

India, the world's main supplier of generic drugs, restricted the export of 26 active pharmaceutical ingredients (APIs) and the medicines made from them, in a move seemingly aimed at tackling possible domestic shortages of medicines.

On Wednesday, Dinesh Dua, chairman of the Pharmaceuticals Export Promotion Council of India (Pharmexcil), told Reuters that some of the restricted APIs and medicines were widely exported to Europe and the United States.

"I am getting a huge number of calls from Europe because it is very sizeably dependent on Indian formulations and we control almost 26 percent of the European formulations in the generic space. So they are panicking," Dua said.

India's list of restricted medicines account for 10 percent of its total pharmaceutical exports and includes several antibiotics, as well as paracetamol, a common pain reliever also sold as acetaminophen.

The restrictions could hurt India's image as a pharmacy to the world and would impact shipments which were already lined up for export at warehouses and ports, Pharmexcil argued in a letter to India's Directorate General of Foreign Trade (DGFT), which was reviewed by Reuters.

"(This) would severely impact our members," said the letter, which urged the government to allow exports of drugs manufactured before the restrictions kicked in.

The DGFT did not respond to a request for comment.

Pharmexcil's Dua told Reuters there were $10 million worth of drugs affected by the curbs currently at Indian ports or close to being readied for export.

Pharmexcil counts dozens of pharmaceutical firms such as Pfizer Ltd (PFIZ.NS) and Abbott (ABOT.NS) among its members. The council falls under the federal commerce ministry.

Indian drug makers rely on China, the source of the virus outbreak, for almost 70 percent of the APIs for their medicines.

Out of the 26 listed as "restricted", 13 APIs are sourced from the Hubei province in China, Dua said.

China's central Hubei province is the epicenter of the outbreak, which has now claimed more than 3,000 lives and infected more than 90,000 people globally.

The curb in exports are likely to impact countries in South East Asia, Latin America and Africa, industry experts said.

World+Biz

Europe / pharmaceutical

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Photo: Collected
    Economic slump drags down growth in VAT collection from big cos
  • It's corruption that bites business harder: CPD
    It's corruption that bites business harder: CPD
  • Import slowdown to affect economic growth: ADB country head
    Import slowdown to affect economic growth: ADB country head

MOST VIEWED

  • FIKE PHOTO: Medical staff moves a patient into a fever clinic at a hospital, as coronavirus disease (COVID-19) outbreaks continue in Shanghai, China, December 19, 2022. REUTERS/Aly Song
    China approves two domestically developed Covid drugs
  • People walk with their luggage at a railway station during the annual Spring Festival travel rush ahead of the Chinese Lunar New Year, as the coronavirus disease (COVID-19) outbreak continues, in Shanghai, China January 16, 2023. REUTERS/Aly Song
    Holiday trips within China surge after lifting of Covid curbs
  • Photo: Collected
    India launches world’s 1st intranasal Covid vaccine
  • A vial of the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022. REUTERS/Hannah Beier
    US CDC still looking at potential stroke risk from Pfizer bivalent Covid shot
  •  A medical worker checks the IV drip treatment of a patient lying on a bed in the emergency department of a hospital, amid the coronavirus disease (COVID-19) outbreak in Shanghai, China, January 5, 2023. REUTERS/Staff
    China says Covid deaths down by nearly 80 percent
  • Sean Bagley, 14, receives the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022. REUTERS/Hannah Beier
    Updated Covid vaccines prevented illness from latest variants -CDC

Related News

  • If Turkey blocks Sweden and Finland, will NATO boot Turkey?
  • Europeans dial down the heating, heed calls to save energy
  • EU plans changes to pharmaceuticals law to avoid medicine shortages
  • Davos 2023: EU to counter US climate game changer with own green deal
  • EU should put Twitter under direct supervision after missteps: German official

Features

Nandita Sharmin's journey to give organic skincare a new identity

Nandita Sharmin's journey to give organic skincare a new identity

18h | Mode
Illustration: TBS

'The silver lining is that the worst is sort of behind us': Hamid Rashid, UN economist

22h | Panorama
Photo: Bloomberg

BuzzFeed and AI are a match made in fad city

21h | Panorama
Snipe in flight. Photo: Enam Ul Haque

Baikka Beel: 'A world where snipe work late'

1d | Panorama

More Videos from TBS

Sarika Sabrin is waiting for a good film

Sarika Sabrin is waiting for a good film

12h | TBS Entertainment
Take your football game to the next level at Next Level academy

Take your football game to the next level at Next Level academy

13h | TBS SPORTS
“Investments risky without consistent policy, reliable data”- SK Bashir Uddin

“Investments risky without consistent policy, reliable data”- SK Bashir Uddin

14h | TBS Round Table
What does Shahrukh has in his 770 million dollar property?

What does Shahrukh has in his 770 million dollar property?

1d | TBS Entertainment

Most Read

1
Picture: Collected
Bangladesh

US Embassy condemns recent incidents of visa fraud

2
Illustration: TBS
Banking

16 banks at risk of capital shortfall if top 3 borrowers default

3
Photo: Collected
Splash

Hansal Mehta responds as Twitter user calls him 'shameless' for making Faraaz

4
A frozen Beyond Burger plant-based patty. Photographer: AKIRA for Bloomberg Businessweek
Bloomberg Special

Fake meat was supposed to save the world. It became just another fad

5
Bapex calls candidates for job test 9 years after advert!
Bangladesh

Bapex calls candidates for job test 9 years after advert!

6
Representational Image
Banking

Cash-strapped Islami, Al-Arafah and National turn to Sonali Bank for costly fund

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]